Nathalie Mazur is a clinician-investigator with a passion for translational research in pediatrics and global health. Her interest and research focus is respiratory syncytial virus (RSV) and maternal vaccination. Her research has created an overview of vaccine development with an urgent message to make vaccines accessible in the developing world, where the majority of the children die. Dr. Mazur aspires to work as a research-oriented clinician scientist in pursuit of an effective low-cost vaccine against RSV.
